{"id":"W2587305350","doi":"10.1111/jdv.14163","title":"Continuous dosing versus interrupted therapy with ixekizumab: an integrated analysis of two phase 3 trials in psoriasis","year":2017,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":67,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre de Recherche Dermatologique du Québec Métropolitain; Hôtel-Dieu de Québec; Université Laval; Probity Medical Research","funders":"Eli Lilly and Company","keywords":"Ixekizumab; Medicine; Psoriasis; Placebo; Dosing; Maintenance therapy; Clinical trial; Phases of clinical research; Internal medicine; Chemotherapy; Dermatology; Pathology; Secukinumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001902546,0.0002324014,0.001747653,0.00058235,0.0001835626,0.00001207196,0.0007607976,0.0002480307,0.00005488058],"category_scores_gemma":[0.0004807223,0.0001348903,0.0003486612,0.0002308273,0.0009485569,0.0001677296,0.0001056786,0.0004865881,0.000001986099],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001838251,"about_ca_system_score_gemma":0.00005579909,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000473194,"about_ca_topic_score_gemma":0.00005586359,"domain_scores_codex":[0.9931396,0.005084094,0.001260819,0.0002115954,0.00005158577,0.0002523434],"domain_scores_gemma":[0.9959297,0.0006872712,0.002947653,0.0002989986,0.00009934854,0.00003698453],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.04857426,0.001615343,0.5160341,0.00003546716,0.02392045,0.0003652903,0.002868639,0.0001322075,0.1022952,0.001395222,0.0002614135,0.3025023],"study_design_scores_gemma":[0.1122845,0.001878552,0.6614346,0.0003696457,0.0109495,0.004274782,0.001088555,0.00008763749,0.2013365,0.0003711405,0.005335369,0.0005892649],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9949293,0.003061686,0.00008032531,0.0008335317,0.0005721351,0.0001323725,0.000029536,0.000006473169,0.0003546767],"genre_scores_gemma":[0.9989007,0.0007623689,0.0001613456,0.00006649907,0.00004282848,0.000001560215,0.00001034044,0.00001555475,0.00003884562],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3019131,"threshold_uncertainty_score":0.5500666,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07432504716928887,"score_gpt":0.3566753525540663,"score_spread":0.2823503053847775,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}